Positive rumblings heard for biotech IPOs

After suffering through doldrums recently, some biotech public offerings this year have been successful and might inspire other IPOs, writes Luke Timmerman. Investments are up as more general-interest investors return to the sector, larger companies are acquiring smaller firms and Congress seems likely to broaden the scope of accelerated approvals. "The real question is, at what point do bigger funds, not just health care specialists, move in to biotech?" asks Bob Nelsen, a managing director at Arch Venture Partners.

View Full Article in:

Biotech IPOs Start to Show Some Modest Signs of Life - Xconomy

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Santa Clara, CA
Director, Site Quality Management
Minneapolis, MN